---
title: 3. Principal risks and risk-reduction measures
---

import Expander from '../../../src/components/Expander'

This learning module discusses noteworthy risks for benzodiazepines. Summaries of product characteristics and the BNF should be consulted for a fuller account of the adverse effects and warnings for individual benzodiazepines.

This learning module discusses the following risks of benzodiazepines:

* [Sedation and other adverse CNS effects (including long-term effects and effects on driving)](/benzodiazepines/CON234573_6)
* [Respiratory adverse effects](/benzodiazepines/CON234573_7)
* [Cardiovascular adverse effects](/benzodiazepines/CON234573_8)
* [Memory impairment](/benzodiazepines/CON234573_9)
* ['Paradoxical effectsâ€™](/benzodiazepines/CON234573_10)
* [Dependence and withdrawal](/benzodiazepines/CON234573_11)
* [Overdose](/benzodiazepines/CON234573_12)
* [Important drug interactions](/benzodiazepines/CON234573_13)


**Precautions and risks associated with special use of benzodiazepines**

* [Pregnancy and breastfeeding](/benzodiazepines/CON234573_15)
* [Elderly](/benzodiazepines/CON234573_16)
* [Benzodiazepines for the management of alcohol withdrawal](/benzodiazepines/CON234573_17)
